IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.365
EU - Europa 25.835
AS - Asia 9.181
SA - Sud America 1.774
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 75
Totale 67.489
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.442
GB - Regno Unito 6.680
RU - Federazione Russa 6.188
SG - Singapore 4.252
IT - Italia 4.026
UA - Ucraina 2.274
DE - Germania 2.118
CN - Cina 1.788
CA - Canada 1.733
BR - Brasile 1.542
DK - Danimarca 1.521
HK - Hong Kong 1.240
VN - Vietnam 921
SE - Svezia 693
IE - Irlanda 524
FI - Finlandia 496
FR - Francia 447
PL - Polonia 326
NL - Olanda 182
IN - India 158
MX - Messico 131
TR - Turchia 119
EU - Europa 106
PK - Pakistan 103
BD - Bangladesh 96
AT - Austria 87
AR - Argentina 82
ID - Indonesia 64
IQ - Iraq 62
IR - Iran 62
ES - Italia 60
KR - Corea 57
AU - Australia 55
JP - Giappone 47
SA - Arabia Saudita 36
ZA - Sudafrica 36
EC - Ecuador 35
RO - Romania 35
UZ - Uzbekistan 33
BE - Belgio 29
CO - Colombia 29
CH - Svizzera 25
SK - Slovacchia (Repubblica Slovacca) 25
VE - Venezuela 25
KE - Kenya 23
PE - Perù 22
CZ - Repubblica Ceca 21
MA - Marocco 20
NZ - Nuova Zelanda 20
AE - Emirati Arabi Uniti 19
LT - Lituania 19
ET - Etiopia 14
BO - Bolivia 13
TN - Tunisia 13
TW - Taiwan 12
AM - Armenia 11
CL - Cile 11
CR - Costa Rica 11
EG - Egitto 11
JO - Giordania 11
PT - Portogallo 10
AZ - Azerbaigian 9
DZ - Algeria 9
IL - Israele 9
JM - Giamaica 9
TT - Trinidad e Tobago 9
NP - Nepal 8
PH - Filippine 8
UY - Uruguay 8
KG - Kirghizistan 7
GH - Ghana 6
KZ - Kazakistan 6
MY - Malesia 6
NO - Norvegia 6
PY - Paraguay 6
AL - Albania 5
BH - Bahrain 5
BY - Bielorussia 5
EE - Estonia 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
BB - Barbados 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
QA - Qatar 4
AO - Angola 3
HR - Croazia 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
RS - Serbia 3
SC - Seychelles 3
SM - San Marino 3
TH - Thailandia 3
Totale 67.456
Salva come PNG Salva come JPEG
Città #
Southend 4.837
Woodbridge 2.672
Singapore 2.434
Chandler 2.319
Ann Arbor 2.295
Houston 2.021
Fairfield 1.626
San Mateo 1.470
Falls Church 1.263
Beijing 1.205
Jacksonville 1.093
Hong Kong 1.042
Seattle 1.040
Dearborn 1.020
Cambridge 959
Wilmington 881
Ashburn 872
Ottawa 857
Moscow 665
Pisa 601
Stevenage 512
Boardman 508
Portsmouth 502
Dublin 500
Chicago 487
Dong Ket 483
The Dalles 453
Montréal 403
Lawrence 385
Beauharnois 315
Warsaw 307
Los Angeles 285
Munich 235
Milan 223
Rome 211
Santa Clara 210
Salt Lake City 205
Brooklyn 204
Redwood City 174
San Diego 168
London 162
Old Bridge 158
Florence 137
São Paulo 130
Buffalo 118
Fremont 110
Tampa 101
Helsinki 97
Frankfurt am Main 96
Elk Grove Village 89
Nuremberg 85
Dallas 83
New York 78
Norwalk 67
Turku 66
Istanbul 65
Central District 60
Livorno 60
Washington 53
Lucca 50
Rio de Janeiro 50
Lappeenranta 48
Kansas City 47
Bologna 43
Buti 42
San Francisco 42
Toronto 42
Lancaster 41
Sterling 41
Belo Horizonte 40
Boston 40
Vienna 38
Seoul 37
Shanghai 37
Genoa 36
Shenzhen 36
Serra 35
Naples 34
Atlanta 33
Nanjing 31
Wayne 31
Brasília 30
Cardiff 30
Tashkent 30
Turin 30
Dulles 29
Mexico City 29
Stockholm 29
Augusta 28
Chiswick 28
Foggia 28
Salisbury 28
Columbus 27
Phoenix 27
Assago 26
Curitiba 26
Montreal 26
Padova 26
Amsterdam 25
Bratislava 25
Totale 41.158
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.493
Value in Healthcare and the Role of the Patient Voice 892
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 609
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 473
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 328
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 305
La neuropatia diabetica 272
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 264
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 256
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 255
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 249
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 249
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 240
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 228
Human pathophysiological adaptations to the space environment 227
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 223
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 217
Treating chemoreflex in heart failure: modulation or demolition? 214
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 214
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 212
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 212
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 212
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 210
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 210
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 208
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 208
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 206
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 206
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 205
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 204
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 204
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 202
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 200
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 200
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 196
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 196
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 196
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 196
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 194
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 193
B-type natriuretic peptide secretion following scuba diving 192
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 192
Marcatori di rimodellamento e fibrosi cardiaca 192
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 191
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 191
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 190
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse. 188
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 188
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 188
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 187
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 187
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 187
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 184
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 184
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 183
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 183
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 183
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 182
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 182
Prediction of the chemoreflex gain by common clinical variables in heart failure 182
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 181
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 181
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 181
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 180
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 180
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 180
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 180
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 180
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 179
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 179
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 179
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 179
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 178
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 178
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 178
Cardiac production of C-type natriuretic peptide in heart failure. 177
Update sui biomarcatori nello scompenso cardiaco. 177
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 177
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 177
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 176
C-type natriuretic peptide and heart failure 175
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 175
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 174
Can we measure how hot the plaque is? Not yet, but…. 174
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 174
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 174
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 173
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 173
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 173
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 173
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 173
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 172
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. 172
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 171
When chronic heart failure intersects chronic obstructive pulmonary disease: impact on long-term prognosis 171
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 171
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure. 170
Hyperthyroidism is associated with lengthening of ventricular repolarization. 170
A simple echocardiographic score to rule out cardiac amyloidosis 170
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 169
Totale 22.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 413.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 413.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.274 719 1.145 522 924 636 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/20261.306 1.306 0 0 0 0 0 0 0 0 0 0 0
Totale 68.116